Skip to main content
STADA Arzneimittel AG logo

STADA Arzneimittel AG — Investor Relations & Filings

Ticker · SAZ ISIN · DE0007251803 LEI · 529900FMTTLMH0P0DL10 HM Manufacturing
Filings indexed 916 across all filing types
Latest filing 2017-09-19 Declaration of Voting R…
Country DE Germany
Listing HM SAZ

About STADA Arzneimittel AG

https://www.stada.com/

STADA Arzneimittel AG is a pharmaceutical company that operates on a three-pillar strategy consisting of generics, consumer healthcare products, and specialty pharmaceuticals. The company is a leading manufacturer of affordable generic medicines, which have been a core part of its business since its founding. In the consumer healthcare segment, STADA markets a wide portfolio of over-the-counter (OTC) products and well-known brands. The specialty pharmaceuticals division focuses on developing and marketing value-added medicines, including an expanding portfolio of biosimilars for therapeutic areas such as oncology, immunology, and bone health.

Recent filings

Filing Released Lang Actions
Declaration of Voting Results & Voting Rights Announcements 2017
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Voting Rights Announcements' and explicitly states that Elliott International, L.P. informed STADA Arzneimittel AG about exceeding the 10% threshold of voting rights, referencing German Securities Trading Act (WpHG) articles related to voting rights notifications. This directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA), which covers official results from shareholder votes or, in this context, significant changes in voting power/shareholding thresholds.
2017-09-19 English
Declaration of Voting Results & Voting Rights Announcements 2017
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Voting Rights Announcements' and explicitly states that Hambledon, Inc. is informing STADA Arzneimittel AG about crossing a threshold of voting rights (exceeding 10%) as required by German Securities Trading Act (WpHG). This type of notification, detailing changes in significant share ownership levels and the intentions behind those holdings, directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is a regulatory announcement, MRQ is a more specific category than the general RNS.
2017-09-19 English
Declaration of Voting Results & Voting Rights Announcements 2017
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and details a notification from Elliott International Capital Advisors Inc. to STADA Arzneimittel AG regarding the exceedance of a voting rights threshold (10%) as required by German Securities Trading Act (WpHG). This directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA), which covers official results from shareholder votes or related announcements like changes in significant ownership stakes that trigger disclosure requirements. Although it involves share ownership changes, the core focus is the formal notification of voting rights status, making DVA the most precise fit over MRQ (Major Shareholding Notification), which is usually for crossing thresholds without the detailed strategic disclosure required here under Sec. 27a WpHG.
2017-09-19 English
Declaration of Voting Results & Voting Rights Announcements 2017
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and details a notification from Elliott Capital Advisors, L.P. regarding the exceedance of a voting rights threshold (10%) in STADA Arzneimittel AG, referencing specific sections of the German Securities Trading Act (WpHG). This directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA), which covers official results from shareholder votes or related announcements like changes in significant shareholdings that trigger disclosure requirements. Although it involves share ownership changes, the primary focus and explicit title point towards a Voting Rights Announcement, making DVA the most precise fit over MRQ (Major Shareholding Notification), which is usually for crossing thresholds without the detailed strategic disclosure required here under WpHG Art. 27a.
2017-09-19 English
Declaration of Voting Results & Voting Rights Announcements 2017
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and details a notification from Braxton Associates, Inc. to STADA Arzneimittel AG regarding the crossing of a voting rights threshold (10%) as required by German Securities Trading Act (WpHG, specifically Art. 27a). This type of filing concerns changes in significant share ownership levels and the intentions behind holding those shares. This aligns perfectly with the definition for 'Major Shareholding Notification' (Code: MRQ). Although the title mentions 'Voting Rights Announcements', the content is a specific notification about shareholding thresholds, which MRQ covers better than DVA (which is for voting *results*).
2017-09-19 English
Declaration of Voting Results & Voting Rights Announcements 2017
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Voting Rights Announcements' and explicitly states that Elliott Asset Management LLC informed STADA Arzneimittel AG pursuant to Art. 27a (1) of the WpHG (German Securities Trading Act) regarding the exceedance of a voting rights threshold (10%). This content directly relates to notifications about changes in significant share ownership levels, which aligns perfectly with the definition for Major Shareholding Notification (MRQ). Although it mentions 'Voting Rights Announcements' in the header, the core content is the notification of crossing a voting rights threshold by a major shareholder.
2017-09-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.